Plus Therapeutics signs 11,370 sq ft lease in Houston; $58,745/mo base rent, 10-yr term starting Nov 2026

PLUS THERAPEUTICS, INC.

Lease covers 11,370 rentable square feet on third floor of 6420 Levit Green Blvd, Houston; 120-month term.
Monthly base rent starts at $58,745, increasing 3% annually; plus share of operating expenses.
Tenant also leases temporary space (Suite 210) at same monthly rent from Oct 16, 2025 until permanent space is ready; first 3 months' rent deferred.
Security deposit and certain terms redacted; parking includes 34 unreserved spaces.
Lease with LG 1 Property Owner LP; Tenant represented by no broker.

item 1.01 item 2.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-244275
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2025-10-21T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.782611+00:00
generated_at: 2026-05-17T02:57:27.562331+00:00
sec_items: ["1.01", "2.03", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-244275
json_url: https://secwatch.observer/filing/0001193125-25-244275.json
markdown_url: https://secwatch.observer/filing/0001193125-25-244275.md
text_url: https://secwatch.observer/filing/0001193125-25-244275.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525244275/0001193125-25-244275-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525244275/d637082d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-244275

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.